Assignee
GW RES LTD
GB·44 granted patents·72 pending applications·1,259 citations·filing 2013–2024
Top patents by PatentIndex Score
116 records- 0199US10709673B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Jul 14, 2020·48 cites·19 claims
- 0298US11963937B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Granted Apr 23, 2024·14 cites·29 claims
- 0398US11766411B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Sep 26, 2023·17 cites·26 claims
- 0498US11701330B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 18, 2023·19 cites·30 claims
- 0598US11633369B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Apr 25, 2023·26 cites·32 claims
- 0698US11590087B2Cannabidiol-type cannabinoid compoundGW RES LTD·Filed 2022·Granted Feb 28, 2023·23 cites·20 claims
- 0798US11446258B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Sep 20, 2022·30 cites·29 claims
- 0898US11357741B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Jun 14, 2022·33 cites·28 claims
- 0998US11154517B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Oct 26, 2021·38 cites·26 claims
- 1098US11154516B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Oct 26, 2021·42 cites·30 claims
- 1198US11096905B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 24, 2021·43 cites·33 claims
- 1298US10966939B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Apr 6, 2021·47 cites·21 claims
- 1398US10849860B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Dec 1, 2020·49 cites·32 claims
- 1498US10709671B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2016·Granted Jul 14, 2020·52 cites·24 claims
- 1598US10709674B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Jul 14, 2020·50 cites·20 claims
- 1698US10603288B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Mar 31, 2020·49 cites·28 claims
- 1797US11684598B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jun 27, 2023·17 cites·17 claims
- 1897US11406623B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusGW RES LTD·Filed 2021·Granted Aug 9, 2022·24 cites·25 claims
- 1997US11400055B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 2, 2022·29 cites·17 claims
- 2097US11160795B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusGW RES LTD·Filed 2021·Granted Nov 2, 2021·38 cites·29 claims
- 2197US11065209B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 20, 2021·43 cites·22 claims
- 2297US10918608B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2015·Granted Feb 16, 2021·50 cites·25 claims
- 2396US11865102B2Cannabidiol preparations and its usesGW RES LTD·Filed 2021·Granted Jan 9, 2024·18 cites·30 claims
- 2496US11793770B27-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Oct 24, 2023·18 cites·12 claims
- 2596US11419829B2Use of cannabidiol in combination with 5-HT2B receptor agonists or amphetamines in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Aug 23, 2022·23 cites·17 claims
- 2696US11229612B2Parenteral formulationsGW RES LTD·Filed 2017·Granted Jan 25, 2022·29 cites·16 claims
- 2796US11207292B2Cannabidiol preparations and its usesGW RES LTD·Filed 2020·Granted Dec 28, 2021·47 cites·26 claims
- 2896US11147783B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2016·Granted Oct 19, 2021·30 cites·19 claims
- 2996US11147776B27-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Oct 19, 2021·33 cites·21 claims
- 3096US10583096B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2017·Granted Mar 10, 2020·35 cites·19 claims
- 3195US11679087B2Use of cannabinoids in the treatment of Angelman syndromeGW RES LTD·Filed 2017·Granted Jun 20, 2023·18 cites·19 claims
- 3294US11426362B2Oral cannabinoid formulationsGW RES LTD·Filed 2018·Granted Aug 30, 2022·27 cites·35 claims
- 3394US11065227B2Use of cannabinoids in the treatment of multiple myelomaGW RES LTD·Filed 2017·Granted Jul 20, 2021·38 cites·16 claims
- 3493US11291631B2Oral cannabinoid formulationsGW RES LTD·Filed 2017·Granted Apr 5, 2022·25 cites·20 claims
- 3593US11160757B1pH dependent release coated microparticle cannabinoid formulationsGW RES LTD·Filed 2020·Granted Nov 2, 2021·36 cites·30 claims
- 3693US11000486B2Combination of cannabinoids in the treatment of leukaemiaGW RES LTD·Filed 2018·Granted May 11, 2021·16 cites·18 claims
- 3792US10098867B2Use of phytocannabinoids in the treatment of ovarian carcinomaGW RES LTD·Filed 2014·Granted Oct 16, 2018·39 cites·3 claims
- 3891US2024165048A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Application pending·0 cites
- 3990US10226433B2Use of cannabinoids in the treatment of degenerative skeletal muscle diseasesGW RES LTD·Filed 2015·Granted Mar 12, 2019·15 cites·4 claims
- 4089US11806319B2Pharmaceutical composition comprising a cannabinoidGW RES LTD·Filed 2019·Granted Nov 7, 2023·16 cites·18 claims
- 4184US10220005B2Synergistic therapies of cannabidiol with hypothermia for neuroprotectionGW RES LTD·Filed 2013·Granted Mar 5, 2019·15 cites·3 claims
- 4284US2022202738A1Cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Application pending·0 cites
- 4380US2024261234A1Use of cannabidiol in the treatment of nocturnal snoringGW RES LTD·Filed 2023·Application pending·0 cites
- 4479US2024207220A1Cannabidiol preparations and its usesGW RES LTD·Filed 2023·Application pending·0 cites
- 4578US2024033229A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Application pending·0 cites
- 4678US2022323375A1Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2022·Application pending·0 cites
- 4777US2020368179A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 4877US2025177321A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2024·Application pending·0 cites
- 4975US2020179303A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 5073US2023032502A1Use of cannabidiol in the treatment of nocturnal snoringGW RES LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 116 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →